Skip to main content
logo
Enorama Pharma AB (publ) (STO:ERMA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.240
+0.848 (216.33%)
Aug 14, 2026, 5:29 PM CET

Enorama Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.182.7415.771.366.8512.8
Revenue Growth
-86.55%-82.63%1061.12%-80.17%-46.50%186.40%
Gross Profit
-7.31-15.043.7-3.9-0.623.9
Operating Income
-57.99-62.12-47.6-41.82-41.97-27.33
Net Income
-65.27-75.14-43.81-44.61-42.03-27.74
Earnings Per Share
-0.90-1.08-0.83-1.61-5.37-4.48
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
17.763.042.096.154.1412.2
Total Debt
---0.441.913.79
Net Cash (Debt)
17.763.042.095.722.238.41
Net Cash Growth
282.14%45.66%-63.53%156.37%-73.49%-
Net Cash Per Share
0.240.040.040.210.281.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-45.27-59.26-35.7-41.35-32.96-30.16
Capital Expenditures
------0.06
Free Cash Flow
-45.27-59.26-35.7-41.35-32.96-30.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--23.48%-287.26%-9.00%30.45%
Operating Margin
-2657.61%-2267.91%-301.87%-3079.82%-612.90%-213.52%
Pretax Margin
-2991.43%-2743.30%-277.82%-3285.20%-613.85%-216.75%
Profit Margin
-2991.43%-2743.30%-277.82%-3285.20%-613.85%-216.75%
FCF Margin
-2074.47%-2163.60%-226.42%-3044.85%-481.35%-236.14%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
42.3952.0112.8984.294.1013.36